Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Assets Average (2011 - 2026)

Mimedx recorded quarterly Assets Average of $325.7 million in Q1 2026, down 1.56% quarter-over-quarter from $330.8 million in Q4 2025, and up 21.9% year-over-year from $267.2 million in Q1 2025.

Mimedx's Assets Average history runs 15 years deep, the most recent figure standing at $325.7 million for Q1 2026.

  • In Q1 2026, Assets Average rose 21.9% year-over-year to $325.7 million; the TTM figure through Mar 2026 stood at $325.7 million (up 21.9% YoY), while the FY2025 annual figure was $303.3 million, up 20.6% from the prior year.
  • Assets Average came in at $325.7 million for Q1 2026 at Mimedx, down from $330.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $330.8 million in Q4 2025 to a low of $169.8 million in Q1 2023.
  • A 5-year average of $228.9 million and a median of $225.9 million in 2024 frame the typical range for Assets Average.
  • Across the five-year window, Assets Average fell 9.22% in 2022 and jumped 35.67% in 2024, its largest moves.
  • Mimedx's Assets Average stood at $172.1 million in 2022, then rose by 24.36% to $214.0 million in 2023, then increased by 18.63% to $253.9 million in 2024, then surged by 30.29% to $330.8 million in 2025, then dropped by 1.56% to $325.7 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $325.7 million, $330.8 million, and $305.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 13.04 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 33.42 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.72 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 331.70 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 40.89 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 26.06 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 26.03 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 40.71 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 5.05 Bn
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn 325.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 325.66 Mn
Dec 31, 2025 330.82 Mn
Sep 30, 2025 305.05 Mn
Jun 30, 2025 280.76 Mn
Mar 31, 2025 267.17 Mn
Dec 31, 2024 253.90 Mn
Sep 30, 2024 237.04 Mn
Jun 30, 2024 225.93 Mn
Mar 31, 2024 230.36 Mn
Dec 31, 2023 214.03 Mn
Sep 30, 2023 182.70 Mn
Jun 30, 2023 172.27 Mn
Mar 31, 2023 169.79 Mn
Dec 31, 2022 172.11 Mn
Sep 30, 2022 170.73 Mn
Jun 30, 2022 171.56 Mn
Mar 31, 2022 181.19 Mn
Dec 31, 2021 184.23 Mn
Sep 30, 2021 183.84 Mn
Jun 30, 2021 188.98 Mn
Mar 31, 2021 196.42 Mn
Dec 31, 2020 207.68 Mn
Sep 30, 2020 182.12 Mn
Jun 30, 2020 154.91 Mn
Mar 31, 2020 163.04 Mn
Dec 31, 2019 173.22 Mn
Sep 30, 2019 174.79 Mn
Jun 30, 2019 138.88 Mn
Mar 31, 2019 115.14 Mn
Dec 31, 2017 149.98 Mn
Sep 30, 2017 189.29 Mn
Jun 30, 2017 194.18 Mn
Mar 31, 2017 152.88 Mn
Dec 31, 2016 149.47 Mn
Sep 30, 2016 179.36 Mn
Jun 30, 2016 177.14 Mn
Mar 31, 2016 156.57 Mn
Dec 31, 2015 130.92 Mn
Sep 30, 2015 119.88 Mn
Jun 30, 2015 109.97 Mn
Mar 31, 2015 107.68 Mn
Dec 31, 2014 103.29 Mn
Sep 30, 2014 91.67 Mn
Jun 30, 2014 86.69 Mn
Mar 31, 2014 86.02 Mn
Dec 31, 2013 65.00 Mn
Sep 30, 2013 42.79 Mn
Jun 30, 2013 39.07 Mn
Mar 31, 2013 36.52 Mn
Dec 31, 2012 34.36 Mn
Sep 30, 2012 30.50 Mn
Jun 30, 2012 27.17 Mn
Mar 31, 2012 26.98 Mn
Dec 31, 2011 25.32 Mn
Sep 30, 2011 23.92 Mn